Study of ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer (TASUKI-52)
Clinical trial NCT03117049 · COMPLETED
Trial details
- NCT number
- NCT03117049
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-13
- Primary completion
- 2020-02-10
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.